COR vs PFE · P/E 21, rev $321.33B vs P/E 20, rev $62.58B
Cencora Inc. (COR) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
COR currently screens at market cap $53.91B and trailing P/E 21.2. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the COR and PFE stock pages for the full models.
Not investment advice.